Results 121 to 130 of about 12,011 (181)

Volatile dimethyl disulphide emission from Burkholderia cepacia LS-044 suppresses metabolism and budding in caspofungin-resistant Nakaseomyces glabratus NT2. [PDF]

Sci Rep
Rahmath NAK, Lin SY, Young CC, Hameed A.
europepmc   +1 more source

Burkholderia cepacia Endocarditis in a Patient With Severe Mitral Annular Calcification. [PDF]

JACC Case Rep
Pepe V, Afari H, O'Quinn RP, Arjoon R.
europepmc   +1 more source

Stability of Burkholderia cepacia Lipase Immobilized on Styrene-Divinylbenzene Activated with Glutaraldehyde, Triton X-100, and Polyethylene Glycol for the Green Synthesis of Hexyl Acetate. [PDF]

Appl Biochem Biotechnol
Correa WM, Osório WR, Bortolozo AD, Poloni E, Padilha GS.   +4 more
europepmc   +1 more source

Activity of antibiotics against Burkholderia cepacia complex in artificial sputum medium. [PDF]

J Antimicrob Chemother
Shukla A, Rodriguez S, Brennan-Krohn T.
europepmc   +1 more source

The First Case of a Cat Infected with Burkholderia pseudomultivorans, a Member of the Burkholderia cepacia Complex. [PDF]

Vet Sci
Fujii Y, Suwa A, Tsuyuki Y, Koyama K, Nio-Kobayashi J, Yoshii K.   +5 more
europepmc   +1 more source

Burkholderia cepacia Infective Endocarditis of Native Aortic Valve: A Case Report and Review of Literature. [PDF]

Cureus
Almubarak I, Almubarak AJ, Ahmed YA, Ali MA, Yusuf WH, Ismail M, Elhadidi S, Abdelaziz H, Gabr MA, Awad G.   +9 more
europepmc   +1 more source

Identification of Burkholderia cepacia Complex: Comparing Conventional, Automated, and Molecular Methods in a Tertiary Care Center. [PDF]

Cureus
Periaiah P, Antony T, Samuel S.
europepmc   +1 more source

Cefiderocol treatment for patients infected by Stenotrophomonas maltophilia, Burkholderia cepacia complex and Achromobacter spp.: subgroup analysis from the PERSEUS study. [PDF]

Eur J Clin Microbiol Infect Dis
Torre-Cisneros J, Ferrer R, Martos CF, Sarda J, Gonzalez Calvo AJ, Verardi S, Karas A, Soriano A.   +7 more
europepmc   +1 more source

Dynamics understanding of novel solvated drug molecules against emerging <i>Burkholderia Cepacia</i> infections in immunocompromised patients.

Results Chem
Ahmad S, Ahmad F, Abideen SA, Khan K, Irfan M, Siddique F, Albekairi NA, Alshammari AM, Wei DQ.   +8 more
europepmc   +1 more source

Some of the next articles are maybe not open access.

Related searches:

Burkholderia cepacia: This Decision Is Overdue

PDA Journal of Pharmaceutical Science and Technology, 2011
This is the third in a series of seven articles discussing the Recall Root Cause Research project conducted by the Division of Manufacturing and Product Quality, Center for Drug Evaluation and Research. This paper reviews the regulatory and scientific impact of a common and recurring opportunistic pathogen, Burkholderia cepacia. B. cepacia is comprised
Lynn, Torbeck, Diane, Raccasi, Dennis E, Guilfoyle, Richard L, Friedman, David, Hussong   +4 more
openaire   +2 more sources